Literature DB >> 29106406

Tuning up T-cell receptors.

C Garrett Rappazzo1, Michael E Birnbaum1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 29106406     DOI： 10.1038/nbt.4009

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  10 in total

Review 1.  Pleiotropic changes controlled by the pre-T-cell receptor.

Authors:  H von Boehmer; I Aifantis; J Feinberg; O Lechner; C Saint-Ruf; U Walter; J Buer; O Azogui
Journal:  Curr Opin Immunol       Date:  1999-04       Impact factor: 7.486

2.  Cancer regression in patients after transfer of genetically engineered lymphocytes.

Authors:  Richard A Morgan; Mark E Dudley; John R Wunderlich; Marybeth S Hughes; James C Yang; Richard M Sherry; Richard E Royal; Suzanne L Topalian; Udai S Kammula; Nicholas P Restifo; Zhili Zheng; Azam Nahvi; Christiaan R de Vries; Linda J Rogers-Freezer; Sharon A Mavroukakis; Steven A Rosenberg
Journal:  Science       Date:  2006-08-31       Impact factor: 47.728

Review 3.  Gammadelta T cell development--having the strength to get there.

Authors:  Daniel J Pennington; Bruno Silva-Santos; Adrian C Hayday
Journal:  Curr Opin Immunol       Date:  2005-04       Impact factor: 7.486

Review 4.  T cell antigen receptor recognition of antigen-presenting molecules.

Authors:  Jamie Rossjohn; Stephanie Gras; John J Miles; Stephen J Turner; Dale I Godfrey; James McCluskey
Journal:  Annu Rev Immunol       Date:  2014-12-10       Impact factor: 28.527

5.  T Cell Receptor Engineering and Analysis Using the Yeast Display Platform.

Authors:  Sheena N Smith; Daniel T Harris; David M Kranz
Journal:  Methods Mol Biol       Date:  2015

6.  Directed evolution of human T-cell receptors with picomolar affinities by phage display.

Authors:  Yi Li; Ruth Moysey; Peter E Molloy; Anne-Lise Vuidepot; Tara Mahon; Emma Baston; Steven Dunn; Nathaniel Liddy; Jansen Jacob; Bent K Jakobsen; Jonathan M Boulter
Journal:  Nat Biotechnol       Date:  2005-02-20       Impact factor: 54.908

Review 7.  Engineered T cells: the promise and challenges of cancer immunotherapy.

Authors:  Andrew D Fesnak; Carl H June; Bruce L Levine
Journal:  Nat Rev Cancer       Date:  2016-08-23       Impact factor: 60.716

8.  Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells.

Authors:  Brian J Cameron; Andrew B Gerry; Joseph Dukes; Jane V Harper; Vivekanandan Kannan; Frayne C Bianchi; Francis Grand; Joanna E Brewer; Minnal Gupta; Gabriela Plesa; Giovanna Bossi; Annelise Vuidepot; Alex S Powlesland; Alison Legg; Katherine J Adams; Alan D Bennett; Nicholas J Pumphrey; Daniel D Williams; Gwendolyn Binder-Scholl; Irina Kulikovskaya; Bruce L Levine; James L Riley; Angel Varela-Rohena; Edward A Stadtmauer; Aaron P Rapoport; Gerald P Linette; Carl H June; Namir J Hassan; Michael Kalos; Bent K Jakobsen
Journal:  Sci Transl Med       Date:  2013-08-07       Impact factor: 17.956

9.  Different affinity windows for virus and cancer-specific T-cell receptors: implications for therapeutic strategies.

Authors:  Milos Aleksic; Nathaniel Liddy; Peter E Molloy; Nick Pumphrey; Annelise Vuidepot; Kyong-Mi Chang; Bent K Jakobsen
Journal:  Eur J Immunol       Date:  2012-10-16       Impact factor: 5.532

10.  Generation of higher affinity T cell receptors by antigen-driven differentiation of progenitor T cells in vitro.

Authors:  Thomas M Schmitt; David H Aggen; Kumiko Ishida-Tsubota; Sebastian Ochsenreither; David M Kranz; Philip D Greenberg
Journal:  Nat Biotechnol       Date:  2017-11-06       Impact factor: 54.908
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.